(BBSI) Barrett Business - Overview
Stock: Payroll Services, Co-Employment, Contract Staffing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.78% |
| Yield on Cost 5y | 1.98% |
| Yield CAGR 5y | -28.14% |
| Payout Consistency | 98.5% |
| Payout Ratio | 22.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.1% |
| Relative Tail Risk | -5.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.47 |
| Alpha | -24.21 |
| Character TTM | |
|---|---|
| Beta | 0.641 |
| Beta Downside | 0.636 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.26% |
| CAGR/Max DD | 0.56 |
Description: BBSI Barrett Business January 19, 2026
Barrett Business Services, Inc. (NASDAQ:BBSI) delivers integrated business-management solutions to U.S. small- and mid-size firms, blending consulting-style knowledge management with HR outsourcing tools. Its core offerings include a co-employment platform that handles payroll, taxes, workers-comp and related administration, as well as staffing and recruiting services ranging from on-demand short-term assignments to long-term on-site management. The company serves a diversified client base across construction, manufacturing, transportation, waste management, retail, hospitality and wholesale trade, and has operated since 1965 from its headquarters in Vancouver, Washington.
Key operating metrics (FY 2023) show revenue of roughly $500 million with a year-over-year growth rate of ~5%, while adjusted EBITDA margins hover near 12%, reflecting the scalability of its SaaS-enabled HR platform. The HR & employment services sector is projected to expand at a 6-7% CAGR through 2028, driven by persistent labor shortages and increasing adoption of outsourced payroll solutions among SMEs. A material risk factor is client concentration: the top 10 customers account for about 20% of total revenue, which could amplify earnings volatility if any large client churns.
For a deeper, data-rich perspective on BBSI’s valuation dynamics, you might explore the ValueRay platform’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 54.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 3.55 > 1.0 |
| NWC/Revenue: 9.01% < 20% (prev 9.66%; Δ -0.65% < -1%) |
| CFO/TA 0.06 > 3% & CFO 43.2m > Net Income 54.9m |
| Net Debt (-22.5m) to EBITDA (81.8m): -0.28 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.3m) vs 12m ago -1.77% < -2% |
| Gross Margin: 21.57% > 18% (prev 0.22%; Δ 2135 % > 0.5%) |
| Asset Turnover: 162.8% > 50% (prev 153.8%; Δ 8.98% > 0%) |
| Interest Coverage Ratio: 414.5 > 6 (EBITDA TTM 81.8m / Interest Expense TTM 178.0k) |
Altman Z'' 2.84
| A: 0.14 (Total Current Assets 516.9m - Total Current Liabilities 406.7m) / Total Assets 777.9m |
| B: 0.27 (Retained Earnings 208.0m / Total Assets 777.9m) |
| C: 0.10 (EBIT TTM 73.8m / Avg Total Assets 751.8m) |
| D: 0.36 (Book Value of Equity 195.7m / Total Liabilities 537.8m) |
| Altman-Z'' Score: 2.84 = A |
Beneish M -2.96
| DSRI: 1.08 (Receivables 300.6m/253.7m, Revenue 1.22b/1.12b) |
| GMI: 1.03 (GM 21.57% / 22.17%) |
| AQI: 0.82 (AQ_t 0.22 / AQ_t-1 0.27) |
| SGI: 1.10 (Revenue 1.22b / 1.12b) |
| TATA: 0.01 (NI 54.9m - CFO 43.2m) / TA 777.9m) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of BBSI shares?
Over the past week, the price has changed by -0.39%, over one month by +0.88%, over three months by +8.55% and over the past year by -11.82%.
Is BBSI a buy, sell or hold?
- StrongBuy: 0
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BBSI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51 | 34.7% |
| Analysts Target Price | 51 | 34.7% |
| ValueRay Target Price | 43 | 13.5% |
BBSI Fundamental Data Overview February 03, 2026
P/E Forward = 16.3934
P/S = 0.7976
P/B = 4.0558
P/EG = 1.1703
Revenue TTM = 1.22b USD
EBIT TTM = 73.8m USD
EBITDA TTM = 81.8m USD
Long Term Debt = 25.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 6.95m USD (from shortTermDebt, last quarter)
Debt = 25.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -22.5m USD (from netDebt column, last quarter)
Enterprise Value = 891.6m USD (976.2m + Debt 25.2m - CCE 109.8m)
Interest Coverage Ratio = 414.5 (Ebit TTM 73.8m / Interest Expense TTM 178.0k)
EV/FCF = 33.32x (Enterprise Value 891.6m / FCF TTM 26.8m)
FCF Yield = 3.00% (FCF TTM 26.8m / Enterprise Value 891.6m)
FCF Margin = 2.19% (FCF TTM 26.8m / Revenue TTM 1.22b)
Net Margin = 4.48% (Net Income TTM 54.9m / Revenue TTM 1.22b)
Gross Margin = 21.57% ((Revenue TTM 1.22b - Cost of Revenue TTM 960.0m) / Revenue TTM)
Gross Margin QoQ = 24.07% (prev 23.81%)
Tobins Q-Ratio = 1.15 (Enterprise Value 891.6m / Total Assets 777.9m)
Interest Expense / Debt = 0.18% (Interest Expense 45.0k / Debt 25.2m)
Taxrate = 22.93% (6.13m / 26.8m)
NOPAT = 56.9m (EBIT 73.8m * (1 - 22.93%))
Current Ratio = 1.27 (Total Current Assets 516.9m / Total Current Liabilities 406.7m)
Debt / Equity = 0.10 (Debt 25.2m / totalStockholderEquity, last quarter 240.1m)
Debt / EBITDA = -0.28 (Net Debt -22.5m / EBITDA 81.8m)
Debt / FCF = -0.84 (Net Debt -22.5m / FCF TTM 26.8m)
Total Stockholder Equity = 225.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.30% (Net Income 54.9m / Total Assets 777.9m)
RoE = 24.36% (Net Income TTM 54.9m / Total Stockholder Equity 225.2m)
RoCE = 29.47% (EBIT 73.8m / Capital Employed (Equity 225.2m + L.T.Debt 25.2m))
RoIC = 25.25% (NOPAT 56.9m / Invested Capital 225.2m)
WACC = 8.08% (E(976.2m)/V(1.00b) * Re(8.28%) + D(25.2m)/V(1.00b) * Rd(0.18%) * (1-Tc(0.23)))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.29%
[DCF Debug] Terminal Value 69.88% ; FCFF base≈26.8m ; Y1≈17.6m ; Y5≈8.01m
Fair Price DCF = 6.91 (EV 154.7m - Net Debt -22.5m = Equity 177.2m / Shares 25.6m; r=8.08% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -42.89 | EPS CAGR: -7.82% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.31 | Revenue CAGR: 5.98% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.08 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.38 | Chg30d=+0.000 | Revisions Net=-3 | Growth EPS=+12.7% | Growth Revenue=+7.5%